---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-013051"
form_type: "8-K"
ticker: "IMNN"
cik: "0000749647"
company_name: "Imunon, Inc."
filed_at: "2025-05-30T23:59:59+00:00"
generated_at: "2026-05-20T05:13:42.197025+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Imunon receives Nasdaq delisting notice for bid price and equity non-compliance

## Summary
- Delisting determination letter received May 28, 2025 for failure to regain $1.00 minimum bid price by May 27, 2025.
- Company not eligible for additional extension due to not meeting $5M minimum stockholders' equity requirement.
- Separate deficiency notice on May 19, 2025 for non-compliance with minimum stockholders' equity under Rule 5550(b)(1).
- Company will request a hearing by June 4, 2025 to appeal; trading suspension stayed pending hearing decision.
- Plans to propose a reverse stock split to regain compliance, subject to board and stockholder approval.

## SEC filing metadata
- accession: 0001641172-25-013051
- form_type: 8-K
- ticker: IMNN
- cik: 0000749647
- company_name: Imunon, Inc.
- filed_at: 2025-05-30T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/749647/000164117225013051/0001641172-25-013051-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/749647/000164117225013051/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-013051
- JSON: https://secwatch.observer/filing/0001641172-25-013051.json
- Plain text: https://secwatch.observer/filing/0001641172-25-013051.txt

## Key facts
- Listing & Compliance Notices
  Imunon, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2), 5810(c)(3)(A)
  source text: November 26, 2024, Imunon, Inc. (“the Company”) received a letter from the staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, based upon the closing bid price of the Company’s common stock, for the previous 30 consecutive business days, the Company was not in compliance with the requirement to maintain a minimum bid price of $1.00 per share (the “Minimum Bid Price Requirement”) for continued listing on The Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Original Notice”). At that time, the Company was provided a compliance period of 180 c
  evidence_url: https://www.sec.gov/Archives/edgar/data/749647/000164117225013051/0001641172-25-013051-index.htm
- Listing & Compliance Notices
  Imunon, Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A), 5505(b), 5550(b)(1), 5810(d)(2)).
  - Exchange: nasdaq
  - Notice: delisting notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2), 5810(c)(3)(A), 5505(b), 5550(b)(1), 5810(d)(2)
  source text: May 28, 2025 (the “Delisting Determination Letter”). As previously reported, the Company received a deficiency letter on May 19, 2025 from the Staff notifying the Company that it is no longer in compliance with the minimum stockholders’ equity requirement (the “Minimum Stockholders’ Equity Requirement”) for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(b)(1). Pursuant to Nasdaq Listing Rule 5810(d)(2), the failure to comply with the Minimum Stockholders’ Equity Requirement has individually become an additional and separate basis for delisting. The Delistin
  evidence_url: https://www.sec.gov/Archives/edgar/data/749647/000164117225013051/0001641172-25-013051-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.